Substrate and product specificities of SET domain methyltransferases
about
Human METTL20 is a mitochondrial lysine methyltransferase that targets the β subunit of electron transfer flavoprotein (ETFβ) and modulates its activityIdentification and characterization of a novel human methyltransferase modulating Hsp70 protein function through lysine methylationHistone methyltransferases: novel targets for tumor and developmental defectsTranscriptional regulation by the Set7 lysine methyltransferaseProtein methylation at the surface and buried deep: thinking outside the histone boxCrystal Structure and Functional Analysis of JMJD5 Indicate an Alternate Specificity and FunctionMultivalent Interactions by the Set8 Histone Methyltransferase With Its Nucleosome SubstrateCatalytic and functional roles of conserved amino acids in the SET domain of the S. cerevisiae lysine methyltransferase Set1A new type of protein lysine methyltransferase trimethylates Lys-79 of elongation factor 1AIdentification of methylated proteins in the yeast small ribosomal subunit: a role for SPOUT methyltransferases in protein arginine methylation.Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memoryETO family protein Mtgr1 mediates Prdm14 functions in stem cell maintenance and primordial germ cell formationCell signaling, post-translational protein modifications and NMR spectroscopyRapid changes in histone deacetylases and inflammatory gene expression in expert meditators.Setd5 is essential for mammalian development and the co-transcriptional regulation of histone acetylation.Regulation of histone H3K4 methylation in brain development and disease.Mapping of Post-translational Modifications of Transition Proteins, TP1 and TP2, and Identification of Protein Arginine Methyltransferase 4 and Lysine Methyltransferase 7 as Methyltransferase for TP2.Saccharomyces cerevisiae Eukaryotic Elongation Factor 1A (eEF1A) Is Methylated at Lys-390 by a METTL21-Like Methyltransferase.Proper Activity of Histone H3 Lysine 4 (H3K4) Methyltransferase Is Required for Morphogenesis during Zebrafish CardiogenesisEngineering of Methylation State Specific 3xMBT Domain Using ELISA Screening.A direct label-free MALDI-TOF mass spectrometry based assay for the characterization of inhibitors of protein lysine methyltransferases.A continuous kinetic assay for protein and DNA methyltransferase enzymatic activities.Differential mRNA expression levels of human histone-modifying enzymes in normal karyotype B cell pediatric acute lymphoblastic leukemia.SET for life: biochemical activities and biological functions of SET domain-containing proteinsPurification, crystallization and X-ray crystallographic studies on a putative methyltransferase, YtqB, from Bacillus subtilis.Histone lysine methylation dynamics: establishment, regulation, and biological impactEpigenetic Regulation.Histone Modifications in Major Depressive Disorder and Related Rodent Models.SETD4 Regulates Cell Quiescence and Catalyzes the Trimethylation of H4K20 during Diapause Formation in Artemia.MLL5 (KMT2E): structure, function, and clinical relevance.Orchestration of H3K27 methylation: mechanisms and therapeutic implication.The HIV-1 Tat Protein Is Monomethylated at Lysine 71 by the Lysine Methyltransferase KMT7Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells.Identification of functionally relevant lysine residues that modulate human farnesoid X receptor activation.Lysine Possesses the Optimal Chain Length for Histone Lysine Methyltransferase Catalysis.Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.Neuronal Deletion of Kmt2a/Mll1 Histone Methyltransferase in Ventral Striatum is Associated with Defective Spike-Timing-Dependent Striatal Synaptic Plasticity, Altered Response to Dopaminergic Drugs, and Increased Anxiety.Emerging Roles for Epigenetic Programming in the Control of Inflammatory Signaling Integration in Heath and Disease.Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential.SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1
P2860
Q24306907-183CE305-0803-45BB-827C-26BFED046E0FQ24315705-F17542FF-AD56-4B70-BACB-035DD6D30011Q26775027-B17F7ABE-DEE2-4770-A9BF-ED81F9D8B0DBQ27009508-4F9F2E46-3630-477E-85C7-7FBA383DF44DQ27025874-D80195AC-4453-4556-895C-DB30EB0B8391Q27671023-156EA078-165A-4F4C-9452-E68ECB81E5FFQ27704231-43B9D2D7-3503-4FC7-A67B-1A4DCB35FBB7Q27935081-270CDAD8-ACCE-4BFC-AE49-287B05B59EF8Q27939199-15A9D481-697D-4E43-8790-AF6229462008Q27939383-115BBE1C-892C-400D-B505-FE4EC03D1038Q28512874-B78CA6B8-623F-4E6D-8E5D-C89A3AB7798BQ28589379-EDB01ADC-E3FE-480E-A861-CCA3757F9BFEQ28830783-65B1A494-37E4-4C98-81E7-0110119654CDQ30579284-89541743-CB2D-4CE3-9D04-4DC1C1FFBB7CQ32874823-FB56FB22-0F6C-4BFD-986C-953A00CB05ACQ34079415-713513B5-B1C6-40A8-9D1D-9E7F279978EBQ35583111-2F642BAB-252A-4816-A1E4-FE79A04001B1Q35675772-80173C23-84C9-446B-909D-1FA8AA02953DQ35749749-B2EBE8DB-6222-4C65-AAAC-8EDCF457F33BQ35998418-99F83907-CEFC-4E72-9AED-A3BB8A6C1DB2Q36340686-53EE9965-699F-4798-92B9-24A56700BDEDQ36370680-33A392B5-9E08-4286-908A-C1518CF0A9DCQ36656083-FAA574DB-FFE3-4C4C-B4D3-1CDA2A73F0DEQ37615671-FF7FDCDB-9363-459B-8A6A-690DE9E3138EQ37685286-94DF0C24-6236-4B8C-B97A-C2F1CF1081CFQ38064095-378B177E-F4C2-4FD9-AB53-23C739DFBE99Q38667118-30DEADDA-5F27-4E1C-BBBE-737590418B16Q38681922-14CCA35A-1739-4908-9131-324A80F28ADCQ38723933-019D796B-2AF7-4C56-A9D3-0DAC7A12C522Q39131004-73F9D58D-4023-4E96-9719-529385539AA6Q39440781-51C9A1FB-4866-46D5-845E-29DD38ACBC3AQ40731101-CA908F1D-5AF0-457F-AA64-5FD011DAD771Q41439912-6CAFF51A-3924-476F-924E-B9D86E748C29Q41943299-8EA06082-5670-4027-98C9-C6CA746A02DFQ47165835-88846217-66D4-4BAC-BA46-0E7EDC98FF67Q47295917-A39D779B-96A3-4E7C-B2E6-D5505EFB762FQ47404387-AA91CBEC-C1FB-43D6-AF1E-F2C5AD88B3ACQ50045989-AB1F73AA-4828-45DE-8328-76FDF02D8DD1Q50209897-BE80E5ED-D087-46E1-AB04-1B29CEE5761AQ58802944-A0AB995C-AE52-4374-A283-014C24153877
P2860
Substrate and product specificities of SET domain methyltransferases
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Substrate and product specificities of SET domain methyltransferases
@ast
Substrate and product specificities of SET domain methyltransferases
@en
Substrate and product specificities of SET domain methyltransferases
@nl
type
label
Substrate and product specificities of SET domain methyltransferases
@ast
Substrate and product specificities of SET domain methyltransferases
@en
Substrate and product specificities of SET domain methyltransferases
@nl
prefLabel
Substrate and product specificities of SET domain methyltransferases
@ast
Substrate and product specificities of SET domain methyltransferases
@en
Substrate and product specificities of SET domain methyltransferases
@nl
P2860
P356
P1433
P1476
Substrate and product specificities of SET domain methyltransferases
@en
P2093
Paul A Del Rizzo
Raymond C Trievel
P2860
P304
P356
10.4161/EPI.6.9.16069
P577
2011-09-01T00:00:00Z